Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Zoom
ZM
|
+$1.14B |
| 2 |
AbbVie
ABBV
|
+$537M |
| 3 |
T-Mobile US
TMUS
|
+$504M |
| 4 |
Baidu
BIDU
|
+$474M |
| 5 |
Kroger
KR
|
+$448M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.32B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$504M |
| 5 |
Humana
HUM
|
+$466M |
Sector Composition
| 1 | Healthcare | 23.45% |
| 2 | Technology | 16.11% |
| 3 | Consumer Staples | 10.59% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2751
Ecovyst
ECVT
$1.06B
| $675K | ﹤0.01% |
51,000
-84,200
| -62% | -$1.11M |
|
|
LITB
2752
LightInTheBox
LITB
$38M
| $673K | ﹤0.01% |
127,737
+50,700
| +66% | +$267K |
|
2753
Traws Pharma
TRAW
$13.5M
| $672K | ﹤0.01% |
+3,166
| New | +$672K |
|
2754
Invesco S&P SmallCap Low Volatility ETF
XSLV
$259M
| $670K | ﹤0.01% |
19,800
-1,600
| -7% | -$54.1K |
|
2755
Astria Therapeutics
ATXS
$419M
| $669K | ﹤0.01% |
17,341
+7,953
| +85% | +$307K |
|
|
VBIV
2756
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $666K | ﹤0.01% |
7,163
-4,264
| -37% | -$396K |
|
2757
Kingsway Financial Services
KFS
$414M
| $665K | ﹤0.01% |
297,142
+32,682
| +12% | +$73.1K |
|
|
AGEN
2758
Agenus
AGEN
$143M
| $664K | ﹤0.01% |
8,613
-15,320
| -64% | -$1.18M |
|
|
NBEV
2759
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
| $663K | ﹤0.01% |
+433,590
| New | +$663K |
|
|
ACCS
2760
ACCESS Newswire Inc.
ACCS
$40.3M
| $663K | ﹤0.01% |
+65,338
| New | +$663K |
|
2761
Lazydays
GORV
$9.34M
| $662K | ﹤0.01% |
+2,533
| New | +$662K |
|
2762
Marker Therapeutics
MRKR
$12.4M
| $662K | ﹤0.01% |
31,962
+8,492
| +36% | +$176K |
|
2763
Vanguard Consumer Discretionary ETF
VCR
$6.58B
| $660K | ﹤0.01% |
+3,300
| New | +$660K |
|
2764
iShares Morningstar Growth ETF
ILCG
$3B
| $657K | ﹤0.01% |
+14,000
| New | +$657K |
|
|
ATRS
2765
DELISTED
Antares Pharma, Inc.
ATRS
| $653K | ﹤0.01% |
237,528
-1,129,086
| -83% | -$3.1M |
|
2766
Vanguard S&P 500 ETF
VOO
$740B
| $652K | ﹤0.01% |
2,300
-2,800
| -55% | -$794K |
|
2767
ImmuCell
ICCC
$53.6M
| $651K | ﹤0.01% |
137,672
+19,800
| +17% | +$93.6K |
|
|
PHLT
2768
Performant Healthcare, Inc. Common Stock
PHLT
$607M
| $650K | ﹤0.01% |
995,939
+33,200
| +3% | +$21.7K |
|
|
AINC
2769
DELISTED
Ashford Inc.
AINC
| $649K | ﹤0.01% |
63,924
+4,941
| +8% | +$50.2K |
|
2770
J. Jill
JILL
$273M
| $647K | ﹤0.01% |
187,084
+42,323
| +29% | +$146K |
|
2771
Affinity Bancshares
AFBI
$123M
| $646K | ﹤0.01% |
70,272
-22
| -0% | -$202 |
|
2772
Tenax Therapeutics
TENX
$27.9M
| $646K | ﹤0.01% |
446
+83
| +23% | +$120K |
|
2773
Dare Bioscience
DARE
$28.4M
| $645K | ﹤0.01% |
54,340
+37,589
| +224% | +$446K |
|
2774
Direxion Daily Emerging Markets Bear 3x Shares
EDZ
$11.6M
| $641K | ﹤0.01% |
+24,500
| New | +$641K |
|
2775
Build-A-Bear
BBW
$977M
| $639K | ﹤0.01% |
293,079
-75,403
| -20% | -$164K |
|